期刊文献+

熊果酸对大鼠血管平滑肌细胞增殖和迁移的影响及机制研究 被引量:5

Study on the effect and mechanism of ursolic acid on the proliferation and migration of rat vascular smooth muscle cells
下载PDF
导出
摘要 目的:使用熊果酸(ursolic acid,UA)干预大鼠血管平滑肌细胞(vascular smooth muscle cell,VSMC),观察对信号转导与转录激活因子3(signal transduction and activator of transcription 3,STAT3)磷酸化蛋白(P-STAT3)表达的影响,观察其对VSMC增殖和迁移能力的影响,并探讨可能的机制。方法:应用不同浓度的UA干预VSMC,采用MTT法检测各组细胞的增殖情况,采用划痕实验观察各组细胞的迁移能力变化,采用Western Blot法检测各组细胞P-STAT3及T-STAT3蛋白的表达改变。结果:10μmol/L或25μmol/L UA可下调VSMC中P-STAT3蛋白的表达;UA可显著抑制细胞的增殖率,当药物浓度为10μmol/L或25μmol/L时,与对照组比较,差异有统计学意义(P<0.05),且25μmol/L组与10μmol/L组组间比较,差异有统计学意义(P<0.05);划痕实验结果显示药物干预后的细胞迁移能力受到抑制。结论:UA可能通过下调P-STAT3表达抑制VSMC的增殖及迁移能力。 Objective: To observe the effect of ursolic acid (UA) on the protein expression of phospho- rylated signal transducer and activator of transcription 3 ( P-STAT3 ) , and the effect on proliferation and migera- tion of rat vascular smooth muscle ceils ( VSMCs), and explore the possible mechanism. Methods : VSMCs were treated with different concentrations of UA (0, 10, 25 umol/L) for 24h. The inhibition of UA on the pro- liferation of VSMCs was measured by MTY assay, scratch wound assay was used to detect the influence of UA on migration of VSMCs, and the expressing of total STAT3 (T-STAT3) and phosphorylated STAT3 (P-STAT3) of VSMCs were detected by Western blot. Results: P-STAT3 expression could be downregulated by UA at con- centration of 10 i.umol/L or 25 i.umol/L; the proliferation of VSMCs was significantly inhibited by UA at the con- centration of 10 umol/L or 25 Ixmol/L ( P 〈0.05 vs. control), and there was a statistical significant difference between 10 umol/L and 25 umol/L of UA (P 〈 0. 05 ) ; meanwhile, the ability of migration of VSMCs was sup- pressed by UA. Conclusion : UA suppressed the proliferation and migration of VSMCs, which may be related to the downregulating the expressing of P-STAT3.
出处 《心肺血管病杂志》 CAS 2013年第5期624-627,共4页 Journal of Cardiovascular and Pulmonary Diseases
基金 国家自然科学基金(NO:30870641 NO:81001005)
关键词 熊果酸 血管平滑肌细胞 信号转导与转录激活因子3 增殖 迁移 Ursolic acid Vascular smooth muscle cells Signal transduction and activator of tran-scription 3 Proliferation Migration
  • 相关文献

参考文献14

  • 1Giangrande PH, Zhang J, Tanner A, et al. Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia. Proc Nail Acad Sci USA, 2007, 104: 12988- 12993. 被引量:1
  • 2Bmmberg JF, Wrzeszczynska MH, Devgan G, et al. Star3 as an oncogene. Cell, 1999, 98: 295-303. 被引量:1
  • 3Liu J. Pharmacology of oleanolic acid and ursolic acid. J Ethno- pharmacol, 1995, 49: 57-68. 被引量:1
  • 4Liu MW, Roubin GS, King SB, et al: Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation, 1989, 79: 1374-1387. 被引量:1
  • 5Bond M, Sala-Newby GB, Wu Y J, et al. Biphasie effect of p21Cipl on smooth muscle cell proliferation: role of PI 3-kinase and Skp2-mediated degradation. Cardiovase Res, 2006, 69: 198-206. 被引量:1
  • 6Zheng H, Xue S, Lian F, et al. A novel promising therapy for vein graft restenosis: overexpressed Nogo-B induces vascular smooth muscle cell apoptosis by activation of the JNK/p38 MAPK signaling pathway. Med Hypotheses, 2011, 77: 278-281. 被引量:1
  • 7Sun J, Zheng J, Ling KH, et al. Preventing intimal thickening of vein grafts in vein artery bypass using STAT-3 siRNA. J Transl Med, 2012. 10: 2. 被引量:1
  • 8Bremberg J, Darnell JE. The role of STATs in transcriptional control and their impact on cellular function. Oncogene, 2000, 19 : 2468-2473. 被引量:1
  • 9Lin L, Hutzen B, Zuo M, et al. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer ceils. Cancer Res, 2010, 70: 2445-2454. 被引量:1
  • 10Lin L, Benson DM, DeAngelis S, et al. A small molecule, LLL12 inhibits constitutive STAT3 and IL-6-induced STAT3 sig- naling and exhibits potent growth suppressive activity in human multiple myeloma cells. Int J Cancer, 2012, 130: 1459-1469. 被引量:1

二级参考文献7

  • 1唐梅,张钲.JAK/STAT信号通路调控血管平滑肌细胞病理生理功能的分子机制[J].国际心血管病杂志,2006,33(4):249-252. 被引量:2
  • 2Schwartz SM. The intimal soil for atherosclerosis and restenosis [J]. Circ Res, 1995 ;77 ( 3 ) :445-65. 被引量:1
  • 3Shibata R, Kai H, Seki Y, et al, Inhibition of STAT3 prevents neointima formation by inhibiting proliferation and promoting apoptosis of neointimal smooth muscle cells[J]. Hum Gene Ther,2003 ;14(7) :601-10. 被引量:1
  • 4Marks AR. Rapamycin: signaling in vascular smooth muscle cell [J]. Transplant Proc,2003 ;35(3 Suppl) :S231-3. 被引量:1
  • 5Owens GK. Molecular regulation of vascular smooth muscle cell differentiation in development and disease [J]. Physiol Rev, 2004 ; 84 ( 3 ) : 767- 801. 被引量:1
  • 6Davies MG, Hagen PO. Pathophysiology of vein graft failure:a revie [J].Eur J Vasc Endovasc Surg, 1995 ;9( 1 ) :7-18. 被引量:1
  • 7Lemson MS. Intimal hyperplasia in vascular grafts[J]. Eur J Vasc Endo- vasc Surg,2000;19(4) :336-50. 被引量:1

同被引文献78

  • 1武继彪,黄文兴,董榕.齐墩果酸对实验性动脉粥样硬化的预防作用[J].中药药理与临床,1991,7(2):24-26. 被引量:10
  • 2赵清,魏盟,赵炳辉,何怡青,刘一文.熊果酸对兔外周血内皮祖细胞数量和功能的影响[J].世界临床药物,2006,27(12):713-717. 被引量:4
  • 3李希波,孙雪飞,尹秋伟,王德江.熊果酸体内抗肺癌作用机制探讨[J].山东大学学报(医学版),2007,45(2):188-191. 被引量:16
  • 4Grech ED.ABC of interventional cardiology:percutaneous coronary intervention.I:history and development.BMJ,2003,326:1080-1082. 被引量:1
  • 5Dorros G,Cowley MJ,Simpson J,et al.Percutaneous transluminal coronary angioplasty:report of complications from the national heart,lung,and blood institute PTCA registry.Circulation,1983,67:723-730. 被引量:1
  • 6Steffel J,Eberli F R,Luscher T F,et al.Drug-eluting stentswhat should be improved?Ann Med,2008,40:242-252. 被引量:1
  • 7Iakovou I,Schmidt T,Bonizzoni E,et al.Incidence,predictors,and outcome of thrombosis after successful implantation of drug-eluting stents.JAMA,2005,293:2126-2130. 被引量:1
  • 8Camenzind E,Steg PG,Wijns W.Stent thrombosis late after implantation of first-generation drug-eluting stents:a cause for concern.Circulation,2007,115:1440-1455. 被引量:1
  • 9Le Tourneau C,Faivre S,Laurence V,et al.Phase I evaluation of seliciclib(R-roscovitine),a novel oral cyclin-dependent kinase inhibitor,in patients with advanced malignancies.Eur J Cancer,2010,46:3243-3250. 被引量:1
  • 10Benson C,White J,De Bono J,et al.A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib(CYC202;R-Roscovitine),administered twice daily for 7 days every 21 days.Br J Cancer,2007,96:29-37. 被引量:1

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部